0

Octreotide

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP83150769
CAS83150-76-9
Structure
MDL NumberMFCD00871400
Molecular Weight1019.24
InChI KeyDEQANNDTNATYII-OULOTJBUSA-N
Description≥98% (HPLC)
SolubilityH2O: soluble
Assay≥98% (HPLC)
Size500μG, 1MG
Storage Conditions−20°C
1

Double-blind, Placebo-Controlled, Randomized Trial of Octreotide in Malignant Bowel Obstruction

David C Currow, Stephen Quinn, Meera Agar, Belinda Fazekas, Janet Hardy, Nikki McCaffrey, Simon Eckermann, Amy P Abernethy, Katherine Clark

J Pain Symptom Manage. 2015 May;49(5):814-21.

PMID: 25462210

1

Octreotide for Congenital and Acquired Chylothorax in Newborns: A Systematic Review

Carlo Bellini, Rita Cabano, Laura C De Angelis, Tommaso Bellini, Maria G Calevo, Paolo Gandullia, Luca A Ramenghi

J Paediatr Child Health. 2018 Aug;54(8):840-847.

PMID: 29602276

1

Octreotide for the Treatment of Sulfonylurea Poisoning

Miguel Glatstein, Dennis Scolnik, Yedidia Bentur

Clin Toxicol (Phila). 2012 Nov;50(9):795-804.

PMID: 23046209

1

Pharmacology of Octreotide: Clinical Implications for Anesthesiologists and Associated Risks

Reza M Borna, Jonathan S Jahr, Susanna Kmiecik, Ken F Mancuso, Alan D Kaye

Anesthesiol Clin. 2017 Jun;35(2):327-339.

PMID: 28526153

1

Somatostatin and Octreotide on the Treatment of Acute Pancreatitis - Basic and Clinical Studies for Three Decades

Jing Li, Rui Wang, Chengwei Tang

Curr Pharm Des. 2011;17(16):1594-601.

PMID: 21548873

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode